Hasdai D, Mathew V, Schwartz R S, Smith L A, Holmes D R, Katusic Z S, Lerman A
Division of Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, Minn. 55905, USA.
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2737-43. doi: 10.1161/01.atv.17.11.2737.
The coronary vasoconstrictor effects of endothelins, mediated by both endothelin ETA and ETB receptors, may be differentially altered in pathophysiological states associated with endothelial dysfunction and elevated endothelin levels. Experimental hypercholesterolemia is associated with coronary endothelial dysfunction and increased circulating endothelin concentrations. These studies were designed to test the hypothesis that experimental hypercholesterolemia is characterized by a differentially altered coronary contractile response to ETA- and ETB-receptor stimulation, in vitro. Pigs were fed either a normal or a high-cholesterol diet for 10 to 13 weeks. Changes in the intraluminal diameter of pressurized small coronary arteries (< 481 +/- 25 microns in diameter) to cumulative concentrations (10(-10) to 10(-6) mol/L) of endothelin-1 (ET-1), and sarafotoxin 6c (S6c), a specific ETB-receptor agonist, were measured using a video dimension analyzer. The maximal contraction attained with ET-1 was greater than with S6c in both normal (86 +/- 7% versus 47 +/- 7%, P = .001) and hypercholesterolemic (77 +/- 6% versus 37 +/- 7%, P < .001) pigs. At 10(-10) mol/L, vessels from hypercholesterolemic pigs manifested greater contraction to both ET-1 (23 +/- 6% versus 8 +/- 3%, P = .02) and S6c (17 +/- 5% versus 4 +/- 2%, P = .02). Incubation of arteries from hypercholesterolemic pigs with BQ-788 (ETB-receptor antagonist), but not FR-139317 (ETA-receptor antagonist), altered the contractile response to ET-1 at 10(-10) mol/L. Removal of the endothelium abolished the difference in response to S6c between normal and hypercholesterolemic pigs. These studies demonstrate that experimental hypercholesterolemia is characterized by enhanced coronary vasoconstriction to endothelins in vitro, the mechanism of which is mediated mainly through the ETB receptor. Thus, the ETB receptor has a role in regulation of coronary artery tone in both the steady-state and pathophysiological states.
内皮素的冠状动脉收缩作用由内皮素ETA和ETB受体介导,在与内皮功能障碍和内皮素水平升高相关的病理生理状态下,可能会有不同程度的改变。实验性高胆固醇血症与冠状动脉内皮功能障碍及循环内皮素浓度升高有关。这些研究旨在验证以下假设:在体外,实验性高胆固醇血症的特征是对ETA和ETB受体刺激的冠状动脉收缩反应发生不同改变。给猪喂食正常或高胆固醇饮食10至13周。使用视频尺寸分析仪测量加压小冠状动脉(直径<481±25微米)对内皮素-1(ET-1)和特定ETB受体激动剂沙拉毒素6c(S6c)累积浓度(10^-10至10^-6摩尔/升)的管腔内直径变化。在正常猪(86±7%对47±7%,P = 0.001)和高胆固醇血症猪(77±6%对37±7%,P < 0.001)中,ET-1引起的最大收缩均大于S6c。在10^-10摩尔/升时,高胆固醇血症猪的血管对ET-1(23±6%对8±%,P = 0.02)和S6c(17±5%对4±2%,P = 0.02)的收缩反应更强。用BQ-788(ETB受体拮抗剂)而非FR-139317(ETA受体拮抗剂)孵育高胆固醇血症猪的动脉,可改变10^-10摩尔/升ET-1时的收缩反应。去除内皮消除了正常猪和高胆固醇血症猪对S6c反应的差异。这些研究表明,实验性高胆固醇血症的特征是体外对内皮素的冠状动脉收缩增强,其机制主要通过ETB受体介导。因此,ETB受体在稳态和病理生理状态下的冠状动脉张力调节中均起作用。